Cyclophosphamide-cisplatin /CPM-CDDP/ versus cyclophosphamide-carboplatin /CPM-CPL/ with and without antiemetic Zofran in the treatment of advanced ovarian cancer / St III-IV/
Krommer, K.
European Journal of Cancer 30A(Suppl 1): S42
1994
ISSN/ISBN: 0959-8049 DOI: 10.1016/0959-8049(94)90861-3
Accession: 030771988
PDF emailed within 0-6 h: $19.90
Related References
Hannigan, E.V.; Green, S.; Alberts, D.S.; O'Toole, R.; Surwit, E. 1993: Results of a Southwest Oncology Group phase IIi trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer Oncology 50(Suppl 2): 2-9Swenerton, K.; Jeffrey, J.; Stuart, G.; Roy, M.; Krepart, G.; Carmichael, J.; Drouin, P.; Stanimir, R.; O'Connell, G.; MacLean, G. 1992: Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group Journal of clinical oncology: official journal of the American Society of Clinical Oncology 10(5): 718-726
Meerpohl, H.G.; Sauerbrei, W.; Kühnle, H.; Schumacher, M.; Pfleiderer, A. 1997: Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA) Gynecologic Oncology 66(1): 75-84
Terashima, Y.; Hirabayashi, M.; Sasaki, H.; Ochiai, K.; Yakushiji, M. 1989: Neoadjuvant chemotherapy with cisplatin cddp adriamycin cyclophosphamide cpm pac in advanced ovarian cancer Gynecologic Oncology 32(1): 108
Heller, S.R.; Macdonald, I.A.; Herbert, M.; Tattersall, R.B. 1987: Influence of sympathetic nervous system on hypoglycaemic warning symptoms Lancet 2(8555): 359-363
Wolf, D.M.; Jordan, V.C. 1992: Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer Gynecologic Oncology 45(2): 118-128
Bolis, G. 1988: Randomised Comparison of Cisplatin with Cyclophosphamide/Cisplatin and with Cyclophosphamide/Doxorubicin/Cisplatin in Advanced Ovarian Cancer Obstetric and Gynecologic Survey 43(3): 179-181
Ginecologia, Interegionale, G.; Oncologico, C. 1987: Randomised Comparison of Cisplatin with Cyclophosphamide/Cisplatin and with Cyclophosphamide/Doxorubicin/ Cisplatin in Advanced Ovarian Cancer The Lancet 330(8555): 353-359
Bolis, G.; Marsoni, S.; Pecorelli, S.; Redaelli, U.; Santoienna, M.; Valsecchi, M.G.; Vassena, L.; Vergadoro, F.; Mangioni, C.; Belloni, C.; Bianchi, U.; Bolis, P.F.; Bortolozzi, G.; Colombo, N.; Epis, A.; Giardina, G.; Natale, N. 1987: Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer Lancet (British Edition) 2(8555): 353-359
Conte, P.F.; Bruzzone, M.; Chiara, S.; Sertoli, M.R.; Daga, M.G.; Rubagotti, A.; Conio, A.; Ruvolo, M.; Rosso, R.; Santi, L. 1986: A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 4(6): 965-971
Conte, P. F.; Bruzzone, M.; Chiara, S.; Sertoli, M. R.; Daga, M. G.; Rubagotti, A.; Conio, A.; Ruvolo, M.; Russo, R.; Santi, L.; Carnino, F.; Cottini, M.; Mossetti, C.; Guercio, E.; Gatti, M.; Siliquini, P. N.; Prelato, M. L.; Durando, C.; Giaccone, G.; Calciati, A.; Farinini, D.; Centonze, M.; Rugiati, S.; Parodi, G.; Messineo, M.; Storace, A.; Bernardini, G.; Misurale, F.; Alessandri, S.; Casini, M.; Ragni, N.; Foglia, G.; Bentivoglio, G.; Pescetto, G. 1987: A Randomized Trial Comparing Cisplatin Plus Cyclophosphamide Versus Cisplatin, Doxorubicin, and Cyclophosphamide in Advanced Ovarian Cancer Obstetric and Gynecologic Survey 42(6): 396-398
Gadducci, A.; Bruzzone, M.; Carnino, F.; Ragni, N.; Rubagotti, A.; Conte, P.F. 1996: Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer International Journal of Gynecological Cancer 6(4): 286-290
Milczek, T.; Klasa-Mazurkiewicz, D.; Sznurkowski, J.; Emerich, J. 2012: Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer Advances in Medical Sciences 57(1): 46-50
Alberts, D.; Mason, N.; Surwit, E.; Weiner, S.; Hammond, N.; Deppe, G. 1985: Phase i trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study Cancer Treatment Reviews 12 Suppl A: 83-92
Krommer, C.F.; Szalai, J.P. 1992: Cyclophosphamide, adriamycin and cisplatin (CAP) versus cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of advanced ovarian cancer : a randomized study Annals of Oncology 3(1): 37-39